Allograft loss in renal transplant recipients with Fabry's disease activated protein C resistance

Gary S. Friedman, Daniel Wik, Linda Silva, J. C. Abdou, H. U. Meier-Kriesche, Bruce Kaplan, Luigi Bonomini, Penny DeFranco, Neil Lyman, Shamkant Mulgaonkar, Martin Jacobs

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Introduction. Fabry's disease is associated with an increased incidence of thrombotic events and rejection. Spontaneous thrombosis of a functioning cadaveric renal allograft in a recipient with Fabry's disease prompted prospective evaluation of all transplant candidates with Fabry's disease for hypercoagulability. Materials and Methods. Transplant candidates with Fabry's disease were tested for hypercoagulability, analyzed for HLA-type and ABO group, and comorbid conditions suggestive of hypercoagulability. Results. A unique association of Fabry's disease with activated protein C Resistance was documented in a cohort of Caucasian male renal transplant recipients with Fabry's disease. Four of five patients were blood group A and had no significant comorbid conditions suggestive of hypercoagulability. The resistance to activation of protein C (APCR)(+) patients shared HLA loci-B8 and Dr3, although the APCR(-) patients shared loci-B27 and -B38. Conclusions. Due to the observed increase in the incidence of APCR in our Fabry's cohort, we suggest screening all patients with Fabry's disease for APCR. Because factor V and factor Va receptors are found on vascular endothelium and peripheral blood monocytes, APCR in the presence of Fabry's disease may be a nonimmunological stimulus for rejection. Analysis of typing in patients with Fabry's disease may further elucidate HLA-based association of Fabry's disease and resistance to activated protein C with the risk of thrombosis and rejection.

Original languageEnglish (US)
Pages (from-to)2099-2102
Number of pages4
JournalTransplantation
Volume69
Issue number10
StatePublished - May 27 2000
Externally publishedYes

Fingerprint

Activated Protein C Resistance
Fabry Disease
Allografts
Kidney
Thrombophilia
Protein C
Thrombosis
Transplant Recipients
HLA-B8 Antigen
Transplants
Disease Resistance
Factor V
Incidence
Vascular Endothelium
Blood Group Antigens
Monocytes

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Friedman, G. S., Wik, D., Silva, L., Abdou, J. C., Meier-Kriesche, H. U., Kaplan, B., ... Jacobs, M. (2000). Allograft loss in renal transplant recipients with Fabry's disease activated protein C resistance. Transplantation, 69(10), 2099-2102.

Allograft loss in renal transplant recipients with Fabry's disease activated protein C resistance. / Friedman, Gary S.; Wik, Daniel; Silva, Linda; Abdou, J. C.; Meier-Kriesche, H. U.; Kaplan, Bruce; Bonomini, Luigi; DeFranco, Penny; Lyman, Neil; Mulgaonkar, Shamkant; Jacobs, Martin.

In: Transplantation, Vol. 69, No. 10, 27.05.2000, p. 2099-2102.

Research output: Contribution to journalArticle

Friedman, GS, Wik, D, Silva, L, Abdou, JC, Meier-Kriesche, HU, Kaplan, B, Bonomini, L, DeFranco, P, Lyman, N, Mulgaonkar, S & Jacobs, M 2000, 'Allograft loss in renal transplant recipients with Fabry's disease activated protein C resistance', Transplantation, vol. 69, no. 10, pp. 2099-2102.
Friedman GS, Wik D, Silva L, Abdou JC, Meier-Kriesche HU, Kaplan B et al. Allograft loss in renal transplant recipients with Fabry's disease activated protein C resistance. Transplantation. 2000 May 27;69(10):2099-2102.
Friedman, Gary S. ; Wik, Daniel ; Silva, Linda ; Abdou, J. C. ; Meier-Kriesche, H. U. ; Kaplan, Bruce ; Bonomini, Luigi ; DeFranco, Penny ; Lyman, Neil ; Mulgaonkar, Shamkant ; Jacobs, Martin. / Allograft loss in renal transplant recipients with Fabry's disease activated protein C resistance. In: Transplantation. 2000 ; Vol. 69, No. 10. pp. 2099-2102.
@article{33a9b882fe7c4eabb72708d78eee4e74,
title = "Allograft loss in renal transplant recipients with Fabry's disease activated protein C resistance",
abstract = "Introduction. Fabry's disease is associated with an increased incidence of thrombotic events and rejection. Spontaneous thrombosis of a functioning cadaveric renal allograft in a recipient with Fabry's disease prompted prospective evaluation of all transplant candidates with Fabry's disease for hypercoagulability. Materials and Methods. Transplant candidates with Fabry's disease were tested for hypercoagulability, analyzed for HLA-type and ABO group, and comorbid conditions suggestive of hypercoagulability. Results. A unique association of Fabry's disease with activated protein C Resistance was documented in a cohort of Caucasian male renal transplant recipients with Fabry's disease. Four of five patients were blood group A and had no significant comorbid conditions suggestive of hypercoagulability. The resistance to activation of protein C (APCR)(+) patients shared HLA loci-B8 and Dr3, although the APCR(-) patients shared loci-B27 and -B38. Conclusions. Due to the observed increase in the incidence of APCR in our Fabry's cohort, we suggest screening all patients with Fabry's disease for APCR. Because factor V and factor Va receptors are found on vascular endothelium and peripheral blood monocytes, APCR in the presence of Fabry's disease may be a nonimmunological stimulus for rejection. Analysis of typing in patients with Fabry's disease may further elucidate HLA-based association of Fabry's disease and resistance to activated protein C with the risk of thrombosis and rejection.",
author = "Friedman, {Gary S.} and Daniel Wik and Linda Silva and Abdou, {J. C.} and Meier-Kriesche, {H. U.} and Bruce Kaplan and Luigi Bonomini and Penny DeFranco and Neil Lyman and Shamkant Mulgaonkar and Martin Jacobs",
year = "2000",
month = "5",
day = "27",
language = "English (US)",
volume = "69",
pages = "2099--2102",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Allograft loss in renal transplant recipients with Fabry's disease activated protein C resistance

AU - Friedman, Gary S.

AU - Wik, Daniel

AU - Silva, Linda

AU - Abdou, J. C.

AU - Meier-Kriesche, H. U.

AU - Kaplan, Bruce

AU - Bonomini, Luigi

AU - DeFranco, Penny

AU - Lyman, Neil

AU - Mulgaonkar, Shamkant

AU - Jacobs, Martin

PY - 2000/5/27

Y1 - 2000/5/27

N2 - Introduction. Fabry's disease is associated with an increased incidence of thrombotic events and rejection. Spontaneous thrombosis of a functioning cadaveric renal allograft in a recipient with Fabry's disease prompted prospective evaluation of all transplant candidates with Fabry's disease for hypercoagulability. Materials and Methods. Transplant candidates with Fabry's disease were tested for hypercoagulability, analyzed for HLA-type and ABO group, and comorbid conditions suggestive of hypercoagulability. Results. A unique association of Fabry's disease with activated protein C Resistance was documented in a cohort of Caucasian male renal transplant recipients with Fabry's disease. Four of five patients were blood group A and had no significant comorbid conditions suggestive of hypercoagulability. The resistance to activation of protein C (APCR)(+) patients shared HLA loci-B8 and Dr3, although the APCR(-) patients shared loci-B27 and -B38. Conclusions. Due to the observed increase in the incidence of APCR in our Fabry's cohort, we suggest screening all patients with Fabry's disease for APCR. Because factor V and factor Va receptors are found on vascular endothelium and peripheral blood monocytes, APCR in the presence of Fabry's disease may be a nonimmunological stimulus for rejection. Analysis of typing in patients with Fabry's disease may further elucidate HLA-based association of Fabry's disease and resistance to activated protein C with the risk of thrombosis and rejection.

AB - Introduction. Fabry's disease is associated with an increased incidence of thrombotic events and rejection. Spontaneous thrombosis of a functioning cadaveric renal allograft in a recipient with Fabry's disease prompted prospective evaluation of all transplant candidates with Fabry's disease for hypercoagulability. Materials and Methods. Transplant candidates with Fabry's disease were tested for hypercoagulability, analyzed for HLA-type and ABO group, and comorbid conditions suggestive of hypercoagulability. Results. A unique association of Fabry's disease with activated protein C Resistance was documented in a cohort of Caucasian male renal transplant recipients with Fabry's disease. Four of five patients were blood group A and had no significant comorbid conditions suggestive of hypercoagulability. The resistance to activation of protein C (APCR)(+) patients shared HLA loci-B8 and Dr3, although the APCR(-) patients shared loci-B27 and -B38. Conclusions. Due to the observed increase in the incidence of APCR in our Fabry's cohort, we suggest screening all patients with Fabry's disease for APCR. Because factor V and factor Va receptors are found on vascular endothelium and peripheral blood monocytes, APCR in the presence of Fabry's disease may be a nonimmunological stimulus for rejection. Analysis of typing in patients with Fabry's disease may further elucidate HLA-based association of Fabry's disease and resistance to activated protein C with the risk of thrombosis and rejection.

UR - http://www.scopus.com/inward/record.url?scp=0034720541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034720541&partnerID=8YFLogxK

M3 - Article

C2 - 10852604

AN - SCOPUS:0034720541

VL - 69

SP - 2099

EP - 2102

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 10

ER -